- Home
- SSSS vs ANL Comparison
SSSS vs ANL Comparison
Compare SSSS & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- ANL
- Stock Information
- Founded
- SSSS 2010
- ANL 2004
- Country
- SSSS United States
- ANL Cayman Islands
- Employees
- SSSS N/A
- ANL N/A
- Industry
- SSSS Finance: Consumer Services
- ANL
- Sector
- SSSS Finance
- ANL
- Exchange
- SSSS Nasdaq
- ANL Nasdaq
- Market Cap
- SSSS 118.1M
- ANL 115.1M
- IPO Year
- SSSS N/A
- ANL 2023
- Fundamental
- Price
- SSSS $4.91
- ANL $2.77
- Analyst Decision
- SSSS Buy
- ANL Strong Buy
- Analyst Count
- SSSS 2
- ANL 2
- Target Price
- SSSS $6.00
- ANL $9.00
- AVG Volume (30 Days)
- SSSS 177.4K
- ANL 29.8K
- Earning Date
- SSSS 11-07-2024
- ANL 08-08-2024
- Dividend Yield
- SSSS N/A
- ANL N/A
- EPS Growth
- SSSS N/A
- ANL N/A
- EPS
- SSSS N/A
- ANL N/A
- Revenue
- SSSS $5,903,895.00
- ANL $5,000,000.00
- Revenue This Year
- SSSS N/A
- ANL N/A
- Revenue Next Year
- SSSS $6.05
- ANL N/A
- P/E Ratio
- SSSS N/A
- ANL N/A
- Revenue Growth
- SSSS 5.43
- ANL N/A
- 52 Week Low
- SSSS $3.32
- ANL $1.85
- 52 Week High
- SSSS $5.44
- ANL $17.48
- Technical
- Relative Strength Index (RSI)
- SSSS 53.68
- ANL 53.97
- Support Level
- SSSS $4.81
- ANL $2.50
- Resistance Level
- SSSS $5.44
- ANL $3.50
- Average True Range (ATR)
- SSSS 0.27
- ANL 0.47
- MACD
- SSSS -0.03
- ANL -0.00
- Stochastic Oscillator
- SSSS 41.11
- ANL 40.48
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.